The relationship between therapeutic effects of gulucocorticoid pulse and lymphcytic surface markers in Graves' ophthalmopathy.

The relationship between therapeutic effects of gulucocorticoid pulse and lymphcytic surface markers in Graves' ophthalmopathy. - The relationship between therapeutic effects of gulucocorticoid pulse and lymphcytic surface markers in Graves' ophthalmopathy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013854

Enrollment

Registered

2014-05-01

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

graves&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients have over moderate and active Graves' ophthalmopathy.

Exclusion criteria

Exclusion criteria: Patients have the other eye disease.

Design outcomes

Primary

Measure	Time frame
We evaluate Lymphcytic surface markers and Clinical activity score and Findings of MRI and Proptosis, Diplopia at before and 3 months after therapy	—

Countries

Japan

Contacts

Public ContactKazuhiko Matsuzawa

Tottori University, Faculty of Medicine Regional Medicine

k.matsuzawa@grape.med.tottori-u.ac.jp0859-38-6661

Outcome results